Benefits of a synbiotic formula (Synbiotic 2000Forte®) in critically ill trauma patients: Early results of a randomized controlled trial

World Journal of Surgery

Volumn 30, Issue 10, 2006, Pages 1848-1855

  Kotzampassi, Katerina ^a   Giamarellos Bourboulis, Evagellos J ^b   Voudouris, Antonios ^a   Kazamias, Pantelis ^c   Eleftheriadis, Efthimios ^a  

^a ARISTOTLE UNIVERSITY MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF ATHENS   (Greece)

^c ICU   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

INULIN; PECTIN; PLACEBO; PROBIOTIC AGENT; STARCH; SYNBIOTIC 2000FORTE; SYNBIOTIC2000FORTE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL STRAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DIARRHEA; DOUBLE BLIND PROCEDURE; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; INFECTION; INTENSIVE CARE UNIT; LACTOBACILLUS PARACASEI; LACTOBACILLUS PLANTARUM; LENGTH OF STAY; LEUCONOSTOC MESENTEROIDES; MALE; MORTALITY; MULTIPLE TRAUMA; PEDIOCOCCUS PENTOSACEUS; RANDOMIZED CONTROLLED TRIAL; SEPSIS; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

CRITICAL ILLNESS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INCIDENCE; MALE; MALTOSE; MIDDLE AGED; MULTIPLE TRAUMA; POLYSACCHARIDES; PROBIOTICS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; TREATMENT OUTCOME;

EID: 33749001956     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-005-0653-1     Document Type: Article

References (33)

1. Deitch EA. Multiple organ failure. Pathophysiology and potential future therapy. Ann Surg 1992;216:117-134.
2. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European prevalence of infection in intensive Care [EPIC] study. EPIC International Advisory Committee. J Am Med Assoc 1995;274:639-644.
3. Marshall JC. Gastrointestinal flora and its alterations in critical illness. Curr Opin Clin Nutr Metabc Care 1999;2:405-411.
4. Isolauri E, Salminen S, Ouwehand AC. Microbial-gut interactions in health and disease. Probiotics. Best Pract Res Clin Gastroenterol 2004;18:299-313.
5. Bengmark S. Econutrition and health maintenance - a new concept to prevent GI inflammation, ulceration and sepsis. Clin Nutr 1996;15:1-10.
6. Kailasapathy K, Chin J. Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol 2000;78:80-88.
7. McNaught CE, Woodcock NP, MacFie J, et al. A prospective randomised study of the probiotic Lactobacillus plantarum 299 V on indices of gut barrier function in elective surgical patients. Gut 2002;51:827-831.
8. Pittet D, Thievent B, Wenzel RP, et al. Importance of preexisting co-morbidities for prognosis of septicemia in critically ill patients. Intensive Care Med 1993;19:265-272.
9. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med 1985;13:818-829.
10. Knaus WA, Draper EA, Wagner DP, et al. Prognosis in acute organ-system failure. Ann Surg 1985;202:685-693.
11. Pittet D, Thievent B, Wenzel RP, et al. Bedside prediction of mortality from bacteremic sepsis. A dynamic analysis of ICU patients. Amer Jl Resp Crit Care Med 1996;153:684-693.
12. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference Definitions for sepsis and multiple organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 1992;20:864-874.
13. Bone RC, Balk RA, Cerra FB, et al. The ACCP/SCCM Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992;101:1656-1662.
14. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med 2000;26:S64-S74.
15. Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections. Am J Infect Control 1988;16:128-140.
16. Chastre J, Fagon JY. Invasive diagnostic testing should be routinely used to manage ventilated patients with suspected pneumonia. Am J Respir Crit Care Med 1994;150:570-574.
17. American Thoracic Society. Hospital-acquired pneumonia in adults: diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. A consensus statement. Am J Respir Crit Care Med 1996;153:1711-1725.
18. Eggimann P, Pittet D. Infection control in the ICU. Chest 2001;120:2059-2093.
19. Brunkhorst FM, Wegscheider K, Forycki ZF, et al. Procalcitonin for early diagnosis and differentiation of SIRS, sepsis, severe sepsis and septic shock. Intensive Care Med 2000;26([Suppl 2]):S148-S152.
20. Zahorec R. Definition for septic syndrome should be reevaluated. Intensive Care Med 2000;26:1870.
21. Giamarellos-Bourboulis EJ, Plachouras D, Tzivra A, et al. Stimulation of innate immunity by susceptible and multidrug-resistant Pseudomonas aeruginosa: an in vitro and in vivo study. Clin Experimental Immunol 2004;135:240-246.
22. Alverdy J, Zaborina O, Wu L. The impact of stress and nutrition on bacterial-host interactions at the intestinal epithelial surface. Curr Opin in Clin Nutr Metab Care 2005;8:205-209.
23. Bengmark S. Synbiotics to strengthen gut barrier function and reduce morbidity in critically ill patients. Clin Nutr 2004;23:441-445.
24. Knight DJW, Girling KJ. Gut flora in health and disease. Lancet 2003;361:1831.
25. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, et al. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004;118:229-241.
26. Gomersall CM. Does the Administration of Lactobacillus to Critically Ill Patients Decrease the Severity of Multi-Organ Dysfunction and Failure? A Pilot Study. London, Roehampton Institute, School of Life Sciences, 1998.
27. Bengmark S, Martindale R. Prebiotics and synbiotics in clinical medicine. Nutr in Clin Pract 2005;20:244-261.
28. Olah A, Belagyi T, Issekutz A, et al. Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis. Br J Surg 2002;89:1103-1107.
29. Duncan C, Dougall H, Johnston P, et al. Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate. Nat Med 1995;1:546-551.
30. Bengmark S. Ecological control of the gastrointestinal tract. The role of probiotic flora. Gut 1998;42:2-7.
31. Wright CE, Rees DD, Moncada S. Protective and pathological role of nitric oxide in endotoxin shock. Cardiovasc Res 1992;26:48-57.
32. Cremonini F, Di Caro S, Nista EC, et al. Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2002;16:1461-1467.
33. D'Souza AL, Rajkumar C, Cooke J, et al. Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis. Br Med J 2002;324:1361.